Cefadroxil
-
Cefadroxil
structure -
-
CAS No:
50370-12-2
-
Formula:
C16H17N3O5S
-
Chemical Name:
Cefadroxil
-
Synonyms:
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-,(6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[amino(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-,[6R-[6α,7β(R*)]]-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2R)-amino(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-,(6R,7R)-;(6R,7R)-7-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;Cefadroxil;BL-S 578;Oracefal;Bidocef;S 578;Cephadroxil;D-Cefadroxil;Ultracef;Roxil;Cefadur;Cipadur;Evacef;Neucef;Helicef;Sumacef;Cefadrox;Ibidroxil
- Categories:
-
CAS No:
Description
Cefadroxil is a broad-spectrum antibiotic of the cephalosporin type, effective in Gram-positive and Gram-negative bacterial infections.
Solid
Cefadroxil is a cephalosporin bearing methyl and (2R)-2-amino-2-(4-hydroxyphenyl)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It has a role as an antibacterial drug. It is a conjugate acid of a cefadroxil(1-).|Long-acting, broad-spectrum, water-soluble, cephalexin derivative.|Cefadroxil anhydrous is a Cephalosporin Antibacterial.|Cefadroxil Anhydrous is the anhydrous form of cefadroxil, a semisynthetic first-generation cephalosporin with antibacterial activity. Cefadroxil binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. PBPs are enzymes involved in the terminal stages of assembling the bacterial cell wall and in reshaping the cell wall during growth and division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis.|Long-acting, broad-spectrum, water-soluble, CEPHALEXIN derivative.
Cefadroxil Basic Attributes
363.39
363.39
256-555-6
Q525PA8JJB
756664
DTXSID8022749
C79562
J01DB05|J - Antiinfectives for systemic use
2941905990
Characteristics
158
-2.1
1.6±0.1 g/cm3
197 °C
789.9°C at 760 mmHg
431.5±32.9 °C
1.728
3.99e-01 g/L
183.1 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]|188.8 Ų [M+H]+ [CCS Type: TW, Method: calibrated with Waters Major Mix]|187.7 Ų [M+Na]+ [CCS Type: TW, Method: calibrated with Waters Major Mix]|183.31 Ų [M-H]-
Safety Information
NONH for all modes of transport
2
36/37/38-42/43
26-36
XI0337000
Xn
P261-P280-P305 + P351 + P338-P342 + P311
H315-H317-H319-H334-H335
|Danger|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P272, P280, P285, P302+P352, P304+P340, P304+P341, P305+P351+P338, P312, P321, P332+P313, P333+P313, P337+P313, P342+P311, P362, P363, P403+P233, P405, and P501|Aggregated GHS information provided by 63 companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Toxicity
Nausea, vomiting, diarrhoea, allergic rashes may occur
Binding rates of cefadroxil were 28.1% by U.F. method
Drug Information
For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes|FDA Label
Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Cefadroxil is well absorbed on oral administration; food does not interfere with its absorption.|Over 90% of the drug is excreted unchanged in the urine within 24 hours. Cefadroxil was detected in the placenta and breast milk.
1.5 hours
Like all beta-lactam antibiotics, cefadroxil binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, causing the inhibition of the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefadroxil interferes with an autolysin inhibitor.
4 Hydroxycephalexin
Cefadroxil Use and Manufacturing
Antibacterial;Bacterialtranspeptidase inhibitor
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients|Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients
Computed Properties
Molecular Weight:363.4
XLogP3:-2.1
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:4
Exact Mass:363.08889182
Monoisotopic Mass:363.08889182
Topological Polar Surface Area:158
Heavy Atom Count:25
Complexity:629
Defined Atom Stereocenter Count:3
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of Cefadroxil
-
CN
3 YRS
Business licensed Certified factoryManufactory Supplier of Semaglutide,Tirzepatide,API,Vitamins,Food AdditiveInquiryCAS No.: 50370-12-2Grade: Pharmaceutical GradeContent: 99%
Learn More Other Chemicals
-
Cefadroxil Hemihydrate
119922-85-9
-
Cefadroxil monohydrate
66592-87-8
-
Cefadroxil Related CoMpound I
147103-94-4
-
Oseltamivir phosphate Formula
204255-11-8
-
Imidazole salicylate Formula
36364-49-5
-
5H-Pyrazolo[1,2-a][1,2,4]triazol-4-ium, 6,7-dihydro-6-mercapto-, chloride (1:1) Formula
153851-71-9
-
Cefminox Structure
75481-73-1
-
Clindamycin Structure
18323-44-9
-
What is Bacitracin Zinc
1405-89-6
-
What is Spectinomycin hydrochloride
21736-83-4